Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJHEF.L Regulatory News (JHEF)

  • There is currently no data for JHEF

Statement re - Fund Termination

16 Aug 2024 11:14

RNS Number : 7903A
Fundlogic SCIBETA HFE Japan Eqty 6F
16 August 2024
Β 

http://www.rns-pdf.londonstockexchange.com/rns/7903A_1-2024-8-16.pdf

Β 

This Notice is sent to you as a shareholder of the SciBeta HFE Japan Equity 6F EW UCITS ETF, a sub- fund of FundLogic Alternatives plc. It is important and requires your immediate attention. If you are in any doubt as to the action to be taken, you should immediately consult your stockbroker, solicitor or attorney or other professional advisor. If you sold or otherwise transferred your holding in the SciBeta HFE Japan Equity 6F EW UCITS ETF, please send this Notice to the stockbroker or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

Β 

This Notice has not been reviewed by the Central Bank of Ireland and it is possible that changes hereto may be necessary to meet the requirements of the Central Bank of Ireland. The Directors are of the opinion that there is nothing contained in this Notice nor in the proposals detailed herein that conflicts with the regulations of the Central Bank of Ireland.

Β 

Defined terms have the same meaning as described in the Company's prospectus dated 1 August 2022, as amended (the "Prospectus") and the supplement in respect of the Fund dated 1 December 2023 (the "Supplement").

Β 

FundLogic Alternatives plc 70 Sir John Rogerson's Quay Dublin 2

Ireland

Β 

(an umbrella fund with segregated liability between sub-funds)

Β 

16 August 2024

Β 

Β 

FundLogic Alternatives plc (the "Company")

SciBeta HFE Japan Equity 6F EW UCITS ETF (the "Fund")

Β 

Dear Shareholder

Β 

As a Shareholder in the Fund, we are writing to inform you that the Directors have resolved to terminate the Fund, with effect from 17 September 2024 (the "Effective Date").

Β 

This decision has been taken because the Fund's value is below the minimum level detailed in the Prospectus, namely US$50,000,000.

Β 

Shareholders may, in accordance with the conditions set out in the Prospectus and the Supplement, redeem their shares in the Fund on each Dealing Day prior to the Effective Date. Any remaining Shareholders will have their shares in the Fund redeemed at the applicable Net Asset Value per Share on the Effective Date. The Fund may commence to liquidate its exposure prior to the Effective Date and accordingly the Fund's exposure may substantially, and increasingly as the Effective Date approaches, consist of cash. Please note that the trading of Shares on the secondary market will continue until the Effective Date or the date at which all Shares are voluntarily redeemed prior to the Effective Date.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Directors: Maurice Murphy, Simon O'Sullivan, Rowena Mallaghan (UK) and David Haydon (UK)

Registered Office: 70 Sir John Rogerson's Quay, Dublin 2, Ireland Companies Registration Office Number 483770

Β 

Β 

Β 

Shareholders are advised to consult their tax advisors regarding the effect of the closure of the Fund. Please contact the Administrator should you require any further information.

Β 

Yours sincerely

Β 

For and on behalf of

the Board of Directors of FundLogic Alternatives plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRPFMMTMTBBBTI
Date   Source Headline
16th Sep 20248:43 amRNSNet Asset Value(s)
13th Sep 20247:49 amRNSNet Asset Value(s)
12th Sep 202410:00 amRNSNet Asset Value(s)
10th Sep 20247:49 amRNSNet Asset Value(s)
9th Sep 20247:43 amRNSNet Asset Value(s)
6th Sep 20248:00 amRNSNet Asset Value(s)
5th Sep 20247:42 amRNSNet Asset Value(s)
4th Sep 20247:49 amRNSNet Asset Value(s)
3rd Sep 20247:20 amRNSNet Asset Value(s)
2nd Sep 20247:55 amRNSNet Asset Value(s)
30th Aug 202411:13 amRNSNet Asset Value(s)
29th Aug 20248:25 amRNSNet Asset Value(s)
28th Aug 20249:33 amRNSNet Asset Value(s)
27th Aug 20247:00 amRNSNet Asset Value(s)
23rd Aug 20247:50 amRNSNet Asset Value(s)
22nd Aug 20247:38 amRNSNet Asset Value(s)
21st Aug 20248:16 amRNSNet Asset Value(s)
20th Aug 20247:34 amRNSNet Asset Value(s)
19th Aug 20247:51 amRNSNet Asset Value(s)
16th Aug 202411:14 amRNSStatement re - Fund Termination
15th Aug 20248:07 amRNSNet Asset Value(s)
14th Aug 20247:52 amRNSNet Asset Value(s)
12th Aug 202411:55 amRNSNet Asset Value(s)
9th Aug 20249:06 amRNSNet Asset Value(s)
8th Aug 20248:13 amRNSNet Asset Value(s)
7th Aug 20247:59 amRNSNet Asset Value(s)
6th Aug 20248:01 amRNSNet Asset Value(s)
2nd Aug 20248:25 amRNSNet Asset Value(s)
1st Aug 202410:12 amRNSNet Asset Value(s)
31st Jul 202411:30 amRNSNet Asset Value(s)
30th Jul 202410:09 amRNSNet Asset Value(s)
29th Jul 202411:37 amRNSNet Asset Value(s)
26th Jul 20247:50 amRNSNet Asset Value(s)
25th Jul 20247:51 amRNSNet Asset Value(s)
24th Jul 20247:51 amRNSNet Asset Value(s)
23rd Jul 20248:06 amRNSNet Asset Value(s)
22nd Jul 20248:20 amRNSNet Asset Value(s)
19th Jul 20243:43 pmRNSNet Asset Value(s)
18th Jul 20248:56 amRNSNet Asset Value(s)
17th Jul 20249:27 amRNSNet Asset Value(s)
15th Jul 20249:53 amRNSNet Asset Value(s)
12th Jul 20247:51 amRNSNet Asset Value(s)
11th Jul 20248:35 amRNSNet Asset Value(s)
10th Jul 20247:42 amRNSNet Asset Value(s)
9th Jul 20247:51 amRNSNet Asset Value(s)
8th Jul 20247:51 amRNSNet Asset Value(s)
5th Jul 20248:55 amRNSNet Asset Value(s)
4th Jul 20248:26 amRNSNet Asset Value(s)
3rd Jul 20249:24 amRNSNet Asset Value(s)
2nd Jul 202410:47 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.